Global Musculoskeletal Diseases Market Report, Industry Analysis and Forecast to 2029

Musculoskeletal Diseases Market Overview:

All acute and chronic disorders affecting the musculoskeletal system are diagnosed and managed under the heading of the musculoskeletal system. Musculoskeletal disorders severely restrict movement and dexterity, which results in early retirement from the workforce, decreased levels of well-being, and a decreased capacity to engage in society. Factors driving the market are rising awareness of the

Musculoskeletal Diseases Market is estimated to reach $6.9 billion by 2029, growing at a CAGR of 5.7% from 2022-2029.

Market Snapshot: 

Musculoskeletal Diseases Market - Report Coverage:

The “Musculoskeletal Diseases Market Report - Forecast (2022-2029)” by Marketlook Consulting, covers an in-depth analysis of the following segments in the Musculoskeletal Diseases Market.

COVID-19 / Ukraine Crisis - Impact Analysis:  

• One of the primary ways that COVID-19 has impacted the musculoskeletal diseases market is through delays in elective procedures. With many hospitals and healthcare facilities overwhelmed by COVID-19 patients, non-essential procedures and surgeries have been postponed or canceled. This has had a significant impact on the musculoskeletal diseases market, as many of these procedures are related to joint replacements, spinal surgeries, and other treatments for musculoskeletal conditions. On the other hand, the pandemic has also created opportunities for telemedicine and remote monitoring technologies, which can help patients manage their musculoskeletal conditions from home. This may lead to a shift in how healthcare is delivered for musculoskeletal diseases, with more emphasis on virtual care and remote monitoring.
• Overall, the COVID-19 pandemic has had a mixed impact on the musculoskeletal diseases market, with some negative effects due to delays in elective procedures and economic factors, but also some potential opportunities for innovation in healthcare delivery.

Segmental Analysis:

Obesity is Growing the Market of Musculoskeletal Diseases

Obesity is a significant risk factor for musculoskeletal diseases such as osteoarthritis and back pain. As the prevalence of obesity continues to rise globally, the incidence of these conditions is also expected to increase. As per World Obesity Federation, around one billion people globally, including 1 in 5 women and 1 in 7 men, will be living with obesity by 2030.

Hospital and Retail Pharmacy Showcasing Significant Growth in Market

Hospitals and retail pharmacies segment both pose strong position in the market due to increase in the demand for musculoskeletal therapies and treatment. These distribution channel contribute significant portion of revenue share in the overall market. Furthermore, the growing trend of routine examination would flourish the growth of musculoskeletal medicine globally.

Rheumatoid Arthritis Captured the Highest Market

In 2021, the segment grabbed the highest market share. This disease has a high prevalence globally thus, has a higher market share in 2022. The surge in the geriatric population and rising chronic inflammatory disorders propel the market growth. The osteoarthritis segment is also propelling in recent years as the incidence among women is growing rapidly. More than 350 million people have arthritis globally and 1 in 4 adults has arthritis in the United States.

Limited Reimbursement and High Competition are Hampering the Market Growth

There is intense competition in the market, with many established players and new entrants vying for market share. This competition puts pressure on prices, and companies must continually innovate to stay ahead. Some musculoskeletal diseases, such as osteoporosis, are not fully reimbursed by insurance companies, making it challenging for patients to afford treatment. This can limit the market size and demand for certain treatments.

North America Maintained a Dominating Position

North America captured the highest market share in 2022. This region is witnessing exponential growth due to an increased use of biological drugs for treating various musculoskeletal diseases along with increased use of medical and healthcare facilities. This is because diseases include rheumatoid arthritis, osteoarthritis, osteoporosis, spondylitis, fibromyalgia, arthralgia, and others are becoming more prevalent in this region.

Musculoskeletal Diseases Market Share (%) By Region, 2022

For More Details on This Report - Request for Sample

Key Market Players: 

Product/Service launches, approvals, patents and events, acquisitions, partnerships and collaborations are key strategies adopted by players in the Musculoskeletal Diseases Market. The top 10 companies in this industry are listed below:

1. Bayer AG
2. Pfizer Inc.
3. Sanofi
4. Zyla Life Sciences
5. Novartis AG
6. Johnson & Johnson Services, Inc.
7. Ampio Pharmaceuticals Inc.
8. Eli Lilly and Company
9. Abbott
10. ABIOGEN PHARMA S.p.A.

Scope of Report: